Terug
42
Dagbereik
€ 29,18
€ 30,31
52-Weeksbereik
€ 23,15
€ 40,72
Volume
703.181
50D / 200D Gem.
€ 32,61
/
€ 34,03
Vorige Slotkoers
€ 30,35
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -57,5 | 0,3 |
| P/B | 4,0 | 2,9 |
| ROE % | -7,1 | 3,7 |
| Net Margin % | -8,9 | 3,8 |
| Rev Growth 5Y % | 69,0 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 47,25
+57.8%
Low: € 36,00
High: € 60,00
Forward WPA
-€ 0,96
Omzet Sch.
450 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,20
€ 5,10 – € 7,14
|
1,1 B | 3 |
| FY2029 |
€ 3,08
€ 2,53 – € 3,55
|
810 M | 3 |
| FY2028 |
-€ 0,01
-€ 0,05 – € 0,04
|
600 M | 9 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 |
Berman David M
HEAD OF R&D
|
sell | 5.965 | € 32,35 | € 192.968 |
| Feb 18, 2026 |
St Leger Tina Amber
CHIEF HR OFFICER
|
sell | 1.000 | € 32,35 | € 32.350 |
| Feb 18, 2026 |
GOLL JOHN
SVP, FINANCE & CAO
|
sell | 698 | € 32,35 | € 22.580 |
| Feb 17, 2026 |
Berman David M
HEAD OF R&D
|
other | 23.648 | — | — |
| Feb 17, 2026 |
St Leger Tina Amber
CHIEF HR OFFICER
|
other | 4.238 | — | — |
| Feb 17, 2026 |
GOLL JOHN
SVP, FINANCE & CAO
|
other | 2.702 | — | — |
| Feb 17, 2026 |
GOLL JOHN
SVP, FINANCE & CAO
|
grant | 28.663 | — | — |
| Nov 28, 2025 |
Berman David M
HEAD OF R&D
|
other | 11.042 | € 17,46 | — |
| Nov 28, 2025 |
Berman David M
HEAD OF R&D
|
sell | 5.521 | € 40,09 | € 221.337 |
| Nov 26, 2025 |
Berman David M
HEAD OF R&D
|
other | 138.808 | € 17,46 | — |
| Nov 26, 2025 |
Berman David M
HEAD OF R&D
|
sell | 69.404 | € 40,12 | € 2.784.488 |
| Nov 24, 2025 |
Berman David M
HEAD OF R&D
|
other | 100 | € 17,46 | € 1.746 |
| Sep 11, 2025 |
Berman David M
HEAD OF R&D
|
other | 38.162 | € 17,46 | — |
| Sep 11, 2025 |
Berman David M
HEAD OF R&D
|
sell | 19.081 | € 36,28 | € 692.259 |
| Sep 10, 2025 |
Berman David M
HEAD OF R&D
|
other | 62.676 | € 17,46 | — |
| Sep 10, 2025 |
Berman David M
HEAD OF R&D
|
sell | 31.338 | € 36,12 | € 1.132.709 |
| Sep 5, 2025 |
Reback Mitch
CHIEF FINANCIAL OFFICER
|
other | 280.316 | — | — |
| Aug 18, 2025 |
Reback Mitch
CHIEF FINANCIAL OFFICER
|
sell | 11.530 | € 9,19 | € 105.961 |
| May 16, 2025 |
Reback Mitch
CHIEF FINANCIAL OFFICER
|
sell | 10.088 | € 15,23 | € 153.640 |
| May 15, 2025 |
Herbst Roy Steven
|
grant | 26.198 | — | — |
Belangrijkste Punten
Revenue grew 68,99% annually over 5 years — strong growth
Debt/Equity of 0,11 — conservative balance sheet
Negative free cash flow of -11,20M
Revenue growth is decelerating — 1Y growth trails 5Y average by 48,89%
Capital efficient — spends only 1,08% of revenue on capex
Groei
Revenue Growth (5Y)
68,99%
Revenue (1Y)20,10%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-7,12%
ROIC-5,96%
Net Margin-8,88%
Op. Margin-11,34%
Veiligheid
Debt / Equity
0,11
Current Ratio4,04
Interest Coverage-2,77
Waardering
P/E Ratio
-57,46
P/B Ratio3,98
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20,10% | Revenue Growth (3Y) | 9,22% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 68,99% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 297,57M | Net Income (TTM) | -26,42M |
| ROE | -7,12% | ROA | -2,48% |
| Gross Margin | 97,91% | Operating Margin | -11,34% |
| Net Margin | -8,88% | Free Cash Flow (TTM) | -11,20M |
| ROIC | -5,96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,11 | Current Ratio | 4,04 |
| Interest Coverage | -2,77 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -57,46 | P/B Ratio | 3,98 |
| P/S Ratio | 5,10 | PEG Ratio | 1,38 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,52B | Enterprise Value | 1,09B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 297,57M | 247,77M | 249,43M | 144,23M | 36,48M |
| Net Income | -26,42M | -40,81M | -55,29M | -43,46M | -180,03M |
| EPS (Diluted) | -0,53 | -1,02 | -1,13 | -0,95 | -3,00 |
| Gross Profit | 291,36M | 239,38M | 248,39M | 138,94M | 36,48M |
| Operating Income | -33,74M | -56,28M | -59,65M | -42,77M | -174,59M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,07B | 1,01B | 597,00M | 526,76M | 407,28M |
| Total Liabilities | 686,24M | 648,79M | 228,16M | 187,86M | 175,76M |
| Shareholders' Equity | 381,03M | 360,72M | 368,84M | 338,90M | 231,53M |
| Total Debt | 43,56M | 432,72M | 84,03M | 81,45M | 86,16M |
| Cash & Equivalents | 467,71M | 455,73M | 442,63M | 402,47M | 321,06M |
| Current Assets | 996,74M | 929,86M | 528,82M | 473,98M | 354,58M |
| Current Liabilities | 246,70M | 212,18M | 139,02M | 100,84M | 82,57M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#83 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026